Methyl jasmonate binds to and detaches mitochondria-bound hexokinase (Q46647628)

23 December 2017

title

Methyl jasmonate binds to and detaches mitochondria-bound hexokinase (English)

1 reference

23 December 2017

1 reference

N Goldin

1

1 reference

23 December 2017

L Arzoine

2

1 reference

23 December 2017

A Heyfets

3

1 reference

23 December 2017

A Israelson

4

1 reference

23 December 2017

Z Zaslavsky

5

1 reference

23 December 2017

T Bravman

6

1 reference

23 December 2017

V Bronner

7

1 reference

23 December 2017

A Notcovich

8

1 reference

23 December 2017

V Shoshan-Barmatz

9

1 reference

23 December 2017

E Flescher

10

1 reference

23 December 2017

language of work or name

English

0 references

publication date

14 April 2008

1 reference

23 December 2017

published in

Oncogene

1 reference

23 December 2017

volume

27

1 reference

23 December 2017

issue

34

1 reference

23 December 2017

page(s)

4636-4643

1 reference

23 December 2017

Involvement of porin N,N-dicyclohexylcarbodiimide-reactive domain in hexokinase binding to the outer mitochondrial membrane

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

The JAZ family of repressors is the missing link in jasmonate signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Oncogenic alterations of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Chemotherapy: targeting the mitochondrial cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Interaction of hexokinase with the outer mitochondrial membrane and a hydrophobic matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Jasmonates--a new family of anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Jasmonates in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Mitochondria as therapeutic targets for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

The pathophysiology of mitochondrial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Duplex strand joining reactions catalyzed by vaccinia virus DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Beginnings of a signal-transduction pathway for bioenergetic control of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

The mitochondrial permeability transition pore complex as a pharmacological target. An introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Mitochondria-bound hexokinase as target for therapy of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Hexokinase II: the integration of energy metabolism and control of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

The cancer cell's "power plants" as promising therapeutic targets: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Lithium detaches hexokinase from mitochondria and inhibits proliferation of B16 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

The voltage-dependent anion channel in endoplasmic/sarcoplasmic reticulum: characterization, modulation and possible function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Direct effect of Taxol on free radical formation and mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Rapid purification of mitochondrial hexokinase from rat brain by a single affinity chromatography step on Affi-Gel blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

The voltage-dependent anion channel-1 modulates apoptotic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

A colorimetric microtiter assay for the quantitation of cytokine activity on adherent cells in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

31 March 2020

Mitochondria in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Hexokinase receptor complex in hepatoma mitochondria: evidence from N,N'-dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Rat brain hexokinase: further studies on the specificity of the hexose and hexose 6-phosphate binding sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

Tumor Mitochondria and the Bioenergetics of Cancer Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.108

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2008.108

1 reference

23 December 2017

1 reference

23 December 2017